Nystatin

Nystatin

2.2 Low risk

Nystatin & Bladder transitional cell carcinoma

38.1%

of users reported Bladder transitional cell carcinoma

62.5%

also reported Hospitalization

100.0%

are women

Most common medical consequences

Hospitalization
62.5%
Severe reaction
37.5%

Have you experienced any negative side effects from this medication?

Nystatin: general information

Most common side effects (4)

Most commonly affected ages

60 - 69 years
75.8%
70 - 79 years
10.1%
80 - 89 years
14.1%
On this page
Nystatin & Bladder transitional cell carcinoma
Nystatin: general information